{"id":"low-dose-oxelidine-group","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2108795","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Oxelidine is a reversible monoamine oxidase (MAO) inhibitor that increases the availability of monoamines such as serotonin, norepinephrine, and dopamine by blocking their enzymatic degradation. At low doses, this mechanism is intended to provide therapeutic benefit while minimizing the risk of hypertensive crisis and other adverse effects associated with higher-dose MAO inhibitor therapy.","oneSentence":"Low-dose oxelidine acts as a monoamine oxidase inhibitor to increase neurotransmitter levels in the central nervous system.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:53:18.103Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Depression"}]},"trialDetails":[{"nctId":"NCT06320041","phase":"PHASE4","title":"Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery","status":"RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2024-08-01","conditions":"Postoperative Pain","enrollment":162}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":65921,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Low dose oxelidine group","genericName":"Low dose oxelidine group","companyName":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","companyId":"the-fourth-affiliated-hospital-of-zhejiang-university-school-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Low-dose oxelidine acts as a monoamine oxidase inhibitor to increase neurotransmitter levels in the central nervous system. Used for Depression, Cognitive impairment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}